title: Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation.
abstract: Among 40 allogeneic stem cell transplant recipients who developed symptomatic respiratory syncytial virus infection, including 22 patients with lower respiratory tract infection, 19 received palivizumab (9 of whom had upper respiratory tract disease). Palivizumab did not prevent progression to lower respiratory infection and had no impact on the overall survival rate.
authors: Hematologie-Greffe, Université Paris 7, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, France.
authors: Flore Sicre
authors: FS
authors: de Fontbrune
authors: Marie
authors: M
authors: Robin
authors: Raphael
authors: R
authors: Porcher
authors: Catherine
authors: C
authors: Scieux
authors: Régis Peffault
authors: RP
authors: de Latour
authors: Christèle
authors: C
authors: Ferry
authors: Vanderson
authors: V
authors: Rocha
authors: Karim
authors: K
authors: Boudjedir
authors: Agnès
authors: A
authors: Devergie
authors: Anne
authors: A
authors: Bergeron
authors: Eliane
authors: E
authors: Gluckman
authors: Elie
authors: E
authors: Azoulay
authors: Jordane
authors: J
authors: Lapalu
authors: Gérard
authors: G
authors: Socié
authors: Patricia
authors: P
authors: Ribaud
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D006402:Hematologic Diseases / Q000150:complications*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008875:Middle Aged; D000069455:Palivizumab; D011014:Pneumonia / Q000188:drug therapy / Q000821:virology; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000821:virology; D012189:Retrospective Studies; D016019:Survival Analysis
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab